The Australian Competition and Consumer Commission has brought proceedings against publicly-traded BlueScope Steel and a former general manager for allegedly engaging in “serious cartel conduct” in relation to the supply of flat steel products in Australia.
Actor Geoffrey Rush has come up short in his bid for an injunction blocking The Daily Telegraph from repeating allegations in the successful defamation case he brought against the publisher, with a judge citing the public interest in free speech and the lack of foundation for the actor’s concerns.
Two units of US pharmaceutical giant Pfizer have filed a lawsuit seeking damages from Juno Pharmaceuticals for allegedly infringing the patent for post-operative pain drug Dynastat.
Allianz Australia will refund over $8 million in fees and premiums to customers who were sold worthless cover they were not eligible to make claims under, including teenagers who were sold death cover.
The Queensland Supreme Court judge has refused to transfer proceedings by villa owners against Clive Palmer’s abandoned Sunshine Coast resort to the Federal Court, but has also rejected a separate bid by Palmer to shut down the case, which has been dormant for six years.
Bellamy’s has lost its appeals court battle to limit the costs incurred by lawyers jointly running two shareholder class actions against the baby food maker.
A judge has signed off on a $40 million settlement reached in shareholder class action against Sirtex, including a $10 million cut for the funders, saying commission rates should reflect the risks taken by funders.
US biotechnology company Regeneron Pharmaceuticals has filed a Federal Court challenge after losing its opposition to a patent application by UK biopharmaceutical company Kymab for a method of producing an animal with part-human DNA.
Rugby league player Jack de Belin has dropped his appeal of a ruling dismissing his challenge to the National Rugby’s League “no fault” stand-down rule.
Westpac has recently agreed to pay a combined $23.25 million to settle two class actions against it, cutting the number of class actions the bank is facing in half.